206 related articles for article (PubMed ID: 19002175)
1. A longitudinal investigation of psychological morbidity in patients with ovarian cancer.
Gonçalves V; Jayson G; Tarrier N
Br J Cancer; 2008 Dec; 99(11):1794-801. PubMed ID: 19002175
[TBL] [Abstract][Full Text] [Related]
2. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study.
Hipkins J; Whitworth M; Tarrier N; Jayson G
Br J Health Psychol; 2004 Nov; 9(Pt 4):569-81. PubMed ID: 15509362
[TBL] [Abstract][Full Text] [Related]
3. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.
Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK
Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955
[TBL] [Abstract][Full Text] [Related]
4. Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.
Stafford L; Komiti A; Bousman C; Judd F; Gibson P; Mann GB; Quinn M
Breast; 2016 Apr; 26():100-5. PubMed ID: 27017248
[TBL] [Abstract][Full Text] [Related]
5. Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
Wen Q; Shao Z; Zhang P; Zhu T; Li D; Wang S
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():85-91. PubMed ID: 28738296
[TBL] [Abstract][Full Text] [Related]
6. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
Sjoquist KM; Friedlander ML; O'Connell RL; Voysey M; King MT; Stockler MR; Oza AM; Gillies K; Martyn JK; Butow PN
Oncologist; 2013; 18(11):1221-8. PubMed ID: 24107972
[TBL] [Abstract][Full Text] [Related]
7. Predictors of anxiety and depression in people with colorectal cancer.
Gray NM; Hall SJ; Browne S; Johnston M; Lee AJ; Macleod U; Mitchell ED; Samuel L; Campbell NC
Support Care Cancer; 2014 Feb; 22(2):307-14. PubMed ID: 24077745
[TBL] [Abstract][Full Text] [Related]
8. Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer.
Beesley VL; Smith DD; Nagle CM; Friedlander M; Grant P; DeFazio A; Webb PM;
Support Care Cancer; 2018 Dec; 26(12):4133-4142. PubMed ID: 29948398
[TBL] [Abstract][Full Text] [Related]
9. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.
Bodurka-Bevers D; Basen-Engquist K; Carmack CL; Fitzgerald MA; Wolf JK; de Moor C; Gershenson DM
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):302-8. PubMed ID: 10985884
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal investigation of psychological disorders in patients prior and subsequent to a diagnosis of ovarian cancer.
Gonçalves V; Jayson G; Tarrier N
J Clin Psychol Med Settings; 2010 Jun; 17(2):167-73. PubMed ID: 20490630
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study.
Liu CL; Liu L; Zhang Y; Dai XZ; Wu H
Health Qual Life Outcomes; 2017 Aug; 15(1):161. PubMed ID: 28818112
[TBL] [Abstract][Full Text] [Related]
12. Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women.
Bish A; Sutton S; Jacobs C; Levene S; Ramirez A; Hodgson S
Br J Cancer; 2002 Jan; 86(1):43-50. PubMed ID: 11857010
[TBL] [Abstract][Full Text] [Related]
13. Intolerance of uncertainty, social support, and loneliness in relation to anxiety and depressive symptoms among women diagnosed with ovarian cancer.
Hill EM; Hamm A
Psychooncology; 2019 Mar; 28(3):553-560. PubMed ID: 30614141
[TBL] [Abstract][Full Text] [Related]
14. Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study.
Hatch R; Young D; Barber V; Griffiths J; Harrison DA; Watkinson P
Crit Care; 2018 Nov; 22(1):310. PubMed ID: 30466485
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
16. The role of positive psychological changes in anxiety and depression of patients with ovarian tumors and their partners: an observational study from the population-based PROFILES registry.
Camara C; Caroline Vos M; de Rooij BH; Pijnenborg JMA; Boll D; van de Poll-Franse LV; Ezendam NPM
Support Care Cancer; 2019 Feb; 27(2):423-431. PubMed ID: 29959575
[TBL] [Abstract][Full Text] [Related]
17. Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer.
Liu H; Yang L
Medicine (Baltimore); 2019 Aug; 98(31):e16620. PubMed ID: 31374028
[TBL] [Abstract][Full Text] [Related]
18. Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.
Reichelt JG; Møller P; Heimdal K; Dahl AA
Fam Cancer; 2008; 7(3):245-54. PubMed ID: 18219587
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers.
Price MA; Butow PN; Costa DS; King MT; Aldridge LJ; Fardell JE; DeFazio A; Webb PM; ;
Med J Aust; 2010 Sep; 193(S5):S52-7. PubMed ID: 21542447
[TBL] [Abstract][Full Text] [Related]
20. Linkages among empathic behaviors, physical symptoms, and psychological distress in patients with ovarian cancer: a pilot study.
Lobchuk MM; Bokhari SA
Oncol Nurs Forum; 2008 Sep; 35(5):808-14. PubMed ID: 18765327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
